透過您的圖書館登入
IP:3.145.164.228
  • 期刊
  • OpenAccess

Method establishment for upgrading chemical markers in pharmacopoeia to bioactive markers for biological standardization of traditional Chinese medicine

摘要


Quality surveillance on authentication, safety and efficacy of proprietary Chinese medicines (pCm) are certainly the top priorities for the industries. Nowadays, the quality control system adopted is mainly chemical marker-oriented, concerning basically the correct use of raw material and safety issues, while the biological activities of the chemical marker(s) are seldom considered. Hence, there is an undefined relationship between the amount of chemical markers and the claimed pharmacological activities. In view of the need in identifying appropriate markers for biological standardization of pCm products, the present study aimed to establish a systematic methodology for verifying whether the chemical marker of a traditional Chinese medicine (TCM) listed in Chinese Pharmacopoeia could be upgraded to a bioactive marker with certain efficacy in treating a particular disease. Our proposed methodology included a series of work on extraction, quantification, literature search and in vivo pharmacological experiments, in which the water extractability, biological effects at theoretical dose and oral bioavailability of the candidate chemical markers were all taken into consideration. The feasibility and implication of this bioactive markers verification methodology were further elaborated. Our findings will serve as the foundation for further research and development of biological standardization of TCM.

參考文獻


State Pharmacopoeia Commission of P. R. China. Pharmacopoeia of the People's Republic of China. vol. 1. Beijing: China Medico-Pharmaceutical Science & Technology Publishing House; 2015.
Lai PKK, To MH, Lau KM, et al. Stachyose: one of the active fibroblast-proliferating components in the root of Rehmannia glutinosa (地黄 dì huáng). J Tradit Complement Med. 2012;2(3):227-234.
Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules. 2011;16(12):10002-10012.
Huang KW, Zhu WF, Su N, et al. Tanshinone IIA vs. salvianolic acid B against cardio-cerebral ischemia. Eval Anal Drug-Use Hosp China. 2009;9(6):449-452 (In Chinese).
Wu Q, Peng Y, Meng QC, Cui HG, Wang XN. Effects of salviandic acid B (SA-B) on activity of basement membrane-type collagenase and impact of regulatory factors in rats with cardiac hypertrophy. China J Chin Mater Med. 2011;36(17): 2388-2392 (In Chinese).

延伸閱讀